1 Mar 2018 - 2 Mar 2018
IET London: Savoy Place
Kymab's Director of Pharmacology and Translational Sciences, Dr. Richard Sainson will be presenting at the 8th Annual Biologics Symposium
Dr. Richard Sainson will discuss KY1044, our novel anti-ICOS antibody, which elicits long term in vivo anti-tumour efficacy as monotherapy or in combination with immune checkpoint inhibitors.
This two day educational event brings together peers from across the biologics community to share information and discuss real life research, techniques and challenges in biological drug development.